Multiple myeloma differential diagnosis: Difference between revisions
Jump to navigation
Jump to search
Hannan Javed (talk | contribs) |
Hannan Javed (talk | contribs) |
||
Line 42: | Line 42: | ||
| | | | ||
* [[Asymptomatic]] | * [[Asymptomatic]] | ||
* | * [[Serum]] [[M protein]] of <30 g/L | ||
* Fewer than 10% [[plasma cells]] in the [[bone marrow]] | |||
* No evidence of [[bone]] or [[Organ (anatomy)|organ]] damage | |||
* | * | ||
|Observation | |Observation | ||
|- | |||
|'''Asymptomatic Plasma Cell Myeloma''' | |||
('''Smoldering''' and '''Indolent plasma cell myeloma''') | |||
| | |||
*[[Chromosomal aberration|Chromosomal aberrations]] or other [[Genetics|genetic]] insults | |||
*[[Malignant]] transformation of [[plasma cells]] | |||
*Clonal [[plasma cell]] proliferation | |||
| | |||
* [[Asymptomatic]] | |||
* [[Serum]] [[M protein]] of >30 g/L | |||
* Greater than 10% [[plasma cells]] in the [[bone marrow]] | |||
* No evidence of [[bone]] or [[Organ (anatomy)|organ]] damage | |||
|Observation | |||
|- | |||
|'''[[Plasma cell leukemia|Plasma Cell Leukemia]]''' | |||
| | |||
* [[Chromosomal aberration|Chromosomal aberrations]] or other [[Genetics|genetic]] insults | |||
* [[Malignant]] transformation of [[plasma cells]] | |||
| | |||
*[[Renal failure]] | |||
*[[Hypercalcemia]] | |||
*[[Cytopenias]] | |||
*No [[bone]] lesions | |||
|[[Chemotherapy]] | |||
|- | |||
|'''[[Plasmacytoma]]''' | |||
| | |||
| | |||
| | |||
|- | |- | ||
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold; text-align:center;" |'''[[Osteoporosis]]''' | | style="padding: 5px 5px; background: #DCDCDC; font-weight: bold; text-align:center;" |'''[[Osteoporosis]]''' |
Revision as of 15:27, 1 November 2018
Multiple myeloma Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Multiple myeloma differential diagnosis On the Web |
American Roentgen Ray Society Images of Multiple myeloma differential diagnosis |
Risk calculators and risk factors for Multiple myeloma differential diagnosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: {}HMHJ} {AE} Haytham Allaham, M.D. [2] Shyam Patel [3]
Overview
Multiple myeloma must be differentiated from other causes of bone lesions such as osteoporosis, osteomalacia, scurvy, osteogenesis imperfecta, and homocystinuria. Each condition has unique causes, features, and treatment.
Differentiating Multiple Myeloma from other Diseases
- The table below summarizes how to differentiate multiple myeloma from other conditions that have a similar presentation:[1]
References
- ↑ "Myeloma - SEER Stat Fact Sheets". Retrieved 17 February 2014.
- ↑ Zuo QY, Wang H, Li W, Niu XH, Huang YH, Chen J; et al. (2017). "Treatment and outcomes of tumor-induced osteomalacia associated with phosphaturic mesenchymal tumors: retrospective review of 12 patients". BMC Musculoskelet Disord. 18 (1): 403. doi:10.1186/s12891-017-1756-1. PMC 5609032. PMID 28934935.
- ↑ Shaker JL, Albert C, Fritz J, Harris G (2015). "Recent developments in osteogenesis imperfecta". F1000Res. 4 (F1000 Faculty Rev): 681. doi:10.12688/f1000research.6398.1. PMC 4566283. PMID 26401268.
- ↑ Kumar A, Palfrey HA, Pathak R, Kadowitz PJ, Gettys TW, Murthy SN (2017). "The metabolism and significance of homocysteine in nutrition and health". Nutr Metab (Lond). 14: 78. doi:10.1186/s12986-017-0233-z. PMC 5741875. PMID 29299040.